Ginkgo Bioworks Holdings, Inc. Stock Price, News & Analysis

Stock performance

Why the stock is moving

DNA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Future catalysts

Recent news

The five most recent related feed items are shown below in reverse chronological order.

1. 01
   2026-07-14 12:13 EST

   Zimmer Biomet Names Chintan Desai President of Asia Pacific Region

   ZBH · Source: Zimmer Biomet

2. 02
   2026-07-13 12:14 EST

   Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results

   ZBH · Source: Zimmer Biomet

3. 03
   2026-07-13 10:59 EST

   U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

   BMY · Source: BMYBristol-Myers Squibb Company

4. 04
   2026-07-13 07:00 EST

   Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer

   GSK · Source: GSK plc

5. 05
   2026-07-10 19:01 EST

   FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)

   MRK · Source: Merck

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions